From the databaseWhat the row says.
Every entry follows the same shape: what is happening, the mechanism, and the recommendation.
Scope
Supplement × Supplement
Last verified
June 4, 2026
CautionInsufficient evidence
What is happening. Both pterostilbene and silymarin from milk thistle are metabolized by hepatic conjugation enzymes (glucuronidation and sulfation), and silymarin can inhibit these pathways. Combined use may alter the clearance of pterostilbene or shared substrates.
Mechanism. Silymarin components inhibit UDP-glucuronosyltransferases and certain CYP enzymes involved in phase I and phase II metabolism, which overlaps with pterostilbene's conjugative clearance pathways.
Recommendation. Use the combination cautiously, especially in people with liver conditions or on hepatically cleared medications. Keep doses moderate and monitor for unexpected effects.
Stack Score
How it moves the number.
Effect on the composite score
If both Milk Thistle and Pterostilbene are in the same stack, this pair applies −5 to your Stack Score (per scored caution row).
The full algorithm, the clamping rules, and four worked stacks are at /methodology/stack-score.
SourcesSources, by evidence tier.
Every claim on this page is cited. PMIDs link straight to PubMed.
Reference material
1- 1Brantley SJ, et al. Two flavonolignans from milk thistle inhibit CYP2C9-mediated metabolism. Drug Metab Dispos. 2010.Needs sourceNo link